Rani Therapeutics Appoints Abe Bassan and Vasudev Bailey to Board of Directors

Rani Therapeutics, a clinical-stage biotherapeutics company specializing in oral delivery of biologics and drugs, announced on October 23, 2025 the appointments of Abraham ('Abe') Bassan and Vasudev Bailey, Ph.D., to its Board of Directors13579.

Abe Bassan is a Partner at Samsara BioCapital, with prior experience at Revolution Medicines and bluebird bio in gene therapy program management135.

Vasudev Bailey is General Partner at Anomaly Ventures and holds advisory roles at Johns Hopkins Medicine and UC Irvine, with a background in management consulting and healthcare technology5.

These appointments coincide with the departure of Andrew Farquharson and Maulik Nanavaty from the board135.

CEO Talat Imran highlighted that Bassan and Bailey bring valuable expertise in therapeutics programs, biomedical engineering, and emerging healthcare technology, supporting Rani's advanced clinical pipeline and recent collaboration with Chugai135.

The company recently closed an oversubscribed $60.3 million private placement led by Samsara BioCapital and Anomaly Ventures, contributing to its financial strength during this period of expansion58111213.

Sources:

1. https://www.biospace.com/press-releases/rani-therapeutics-announces-the-appointments-of-abe-bassan-and-vasudev-bailey-ph-d-to-board-of-directors

3. https://www.stocktitan.net/news/RANI/rani-therapeutics-announces-the-appointments-of-abe-bassan-and-y2ditf7jla1z.html

5. https://www.investing.com/news/company-news/rani-therapeutics-adds-two-biotech-investors-to-board-of-directors-93CH-4306068

7. https://www.tradingview.com/news/reuters.com,2025:newsml_TUACB4WKZ:0-rani-therapeutics-announces-the-appointments-of-abe-bassan-and-vasudev-bailey-ph-d-to-board-of-directors/

8. https://www.stocktitan.net/news/RANI/rani-therapeutics-announces-oversubscribed-60-3-million-private-ozktmj22dg5s.html

9. https://www.marketscreener.com/news/rani-therapeutics-announces-the-appointments-of-abe-bassan-and-vasudev-bailey-ph-d-to-board-of-dir-ce7d5dd8d08bf022

11. https://www.globenewswire.com/news-release/2025/10/23/3172417/0/en/Rani-Therapeutics-Announces-Closing-of-Oversubscribed-60-3-Million-Private-Placement-Priced-At-the-Market-under-Nasdaq-Rules.html

12. https://www.streetinsider.com/Board+Changes/Rani+Therapeutics+adds+two+directors,+closes+$60.3+million+funding/25494978.html

13. https://www.marketscreener.com/news/rani-therapeutics-announces-closing-of-oversubscribed-60-3-million-private-placement-priced-at-the-ce7d5dd8d08bf12c